| Year |
Citation |
Score |
| 2020 |
Yang SZ, Xu F, Yuan K, Sun Y, Zhou T, Zhao X, McDonald JM, Chen Y. Regulation of pancreatic cancer TRAIL resistance by protein O-GlcNAcylation. Laboratory Investigation; a Journal of Technical Methods and Pathology. PMID 31896813 DOI: 10.1038/S41374-019-0365-Z |
0.343 |
|
| 2019 |
Xu F, Sun Y, Yang SZ, Zhou T, Jhala N, McDonald J, Chen Y. Cytoplasmic PARP-1 Promotes Pancreatic Cancer Tumorigenesis and Resistance. International Journal of Cancer. PMID 30614530 DOI: 10.1002/Ijc.32108 |
0.417 |
|
| 2017 |
Yang SZ, Xu F, Zhou T, Zhao X, McDonald JM, Chen Y. The long non-coding RNA HOTAIR enhances pancreatic cancer resistance to TNF-related apoptosis inducing ligand. The Journal of Biological Chemistry. PMID 28476883 DOI: 10.1074/Jbc.M117.786830 |
0.39 |
|
| 2015 |
Yuan K, Yong S, Xu F, Zhou T, McDonald JM, Chen Y. Calmodulin antagonists promote TRA-8 therapy of resistant pancreatic cancer. Oncotarget. PMID 26320171 DOI: 10.18632/Oncotarget.4490 |
0.447 |
|
| 2014 |
Fancy RM, Wang L, Napier T, Lin J, Jing G, Lucius AL, McDonald JM, Zhou T, Song Y. Characterization of calmodulin-Fas death domain interaction: an integrated experimental and computational study. Biochemistry. 53: 2680-8. PMID 24702583 DOI: 10.1021/Bi500228H |
0.41 |
|
| 2014 |
Yuan K, Zhou T, McDonald J, Chen Y. Abstract 2268: Augmentation of DR5 expression by calmodulin antagonists sensitizes TRA-8-induced apoptosis in pancreatic cancer Cancer Research. 74: 2268-2268. DOI: 10.1158/1538-7445.Am2014-2268 |
0.466 |
|
| 2013 |
Yuan K, Sun Y, Zhou T, McDonald J, Chen Y. PARP-1 regulates resistance of pancreatic cancer to TRAIL therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 4750-9. PMID 23833311 DOI: 10.1158/1078-0432.Ccr-13-0516 |
0.337 |
|
| 2013 |
Yan Q, McDonald JM, Zhou T, Song Y. Structural insight for the roles of fas death domain binding to FADD and oligomerization degree of the Fas-FADD complex in the death-inducing signaling complex formation: a computational study. Proteins. 81: 377-85. PMID 23042204 DOI: 10.1002/Prot.24193 |
0.384 |
|
| 2013 |
Yuan K, Zhou T, McDonald J, Chen Y. Abstract 2953: Inhibition of calmodulin enhances TRA-8-induced apoptosis in pancreatic cancer cells . Cancer Research. 73: 2953-2953. DOI: 10.1158/1538-7445.Am2013-2953 |
0.476 |
|
| 2013 |
Yuan K, Sun Y, Zhou T, McDonald J, Chen Y. Abstract 2947: PARP-1 regulates death receptor 5-mediated apoptosis in pancreatic cancer. Cancer Research. 73: 2947-2947. DOI: 10.1158/1538-7445.Am2013-2947 |
0.453 |
|
| 2012 |
Jing G, Yuan K, Liang Q, Sun Y, Mao X, McDonald JM, Chen Y. Reduced CaM/FLIP binding by a single point mutation in c-FLIP(L) modulates Fas-mediated apoptosis and decreases tumorigenesis. Laboratory Investigation; a Journal of Technical Methods and Pathology. 92: 82-90. PMID 21912376 DOI: 10.1038/Labinvest.2011.131 |
0.426 |
|
| 2012 |
Fancy R, Napier T, Jing G, McDonald JM, Zhou T, Song Y. Abstract 4754: Quantitative characterization of calmodulin and Fas death domain interactions Cancer Research. 72: 4754-4754. DOI: 10.1158/1538-7445.Am2012-4754 |
0.429 |
|
| 2012 |
Yuan K, Zhou T, McDonald J, Chen Y. Abstract 246: Calmodulin binding to death receptor-5 regulates pancreatic cancer apoptosis Cancer Research. 72: 246-246. DOI: 10.1158/1538-7445.Am2012-246 |
0.463 |
|
| 2011 |
Pan D, Yan Q, Chen Y, McDonald JM, Song Y. Trifluoperazine regulation of calmodulin binding to Fas: a computational study. Proteins. 79: 2543-56. PMID 21656570 DOI: 10.1002/Prot.23081 |
0.403 |
|
| 2011 |
Yuan K, Jing G, Chen J, Liu H, Zhang K, Li Y, Wu H, McDonald JM, Chen Y. Calmodulin mediates Fas-induced FADD-independent survival signaling in pancreatic cancer cells via activation of Src-extracellular signal-regulated kinase (ERK). The Journal of Biological Chemistry. 286: 24776-84. PMID 21613217 DOI: 10.1074/Jbc.M110.202804 |
0.473 |
|
| 2011 |
Pan G, Zheng R, Yang P, Li Y, Clancy JP, Liu J, Feng X, Garber DA, Spearman P, McDonald JM. Nucleosides accelerate inflammatory osteolysis, acting as distinct innate immune activators. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 26: 1913-25. PMID 21472777 DOI: 10.1002/Jbmr.400 |
0.344 |
|
| 2011 |
Jing G, Yuan K, Turk AN, Jhala NC, Arnoletti JP, Zhang K, McDonald JM, Chen Y. Tamoxifen enhances therapeutic effects of gemcitabine on cholangiocarcinoma tumorigenesis. Laboratory Investigation; a Journal of Technical Methods and Pathology. 91: 896-904. PMID 21464824 DOI: 10.1038/Labinvest.2011.60 |
0.477 |
|
| 2011 |
Feng X, McDonald JM. Disorders of bone remodeling. Annual Review of Pathology. 6: 121-45. PMID 20936937 DOI: 10.1146/Annurev-Pathol-011110-130203 |
0.313 |
|
| 2011 |
Saxena R, Pan G, Dohm ED, McDonald JM. Modeled microgravity and hindlimb unloading sensitize osteoclast precursors to RANKL-mediated osteoclastogenesis. Journal of Bone and Mineral Metabolism. 29: 111-22. PMID 20589403 DOI: 10.1007/S00774-010-0201-4 |
0.627 |
|
| 2011 |
Jing G, Yuan K, Turk AN, McDonald JM, Chen Y. Abstract 4089: Calmodulin antagonists inhibit cholangiocarcinoma tumorigenesis independent of gemcitabine by the activating of caspase 2 Cancer Research. 71: 4089-4089. DOI: 10.1158/1538-7445.Am2011-4089 |
0.474 |
|
| 2011 |
Yan Q, McDonald JM, Song Y. Abstract 19: Structural insight for the role of Fas binding to FADD and oligomerization degree of Fas/FADD complex in death inducing signaling complex formation Cancer Research. 71: 19-19. DOI: 10.1158/1538-7445.Am2011-19 |
0.406 |
|
| 2010 |
Williams JP, Micoli K, McDonald JM. Calmodulin-an often-ignored signal in osteoclasts. Annals of the New York Academy of Sciences. 1192: 358-64. PMID 20392260 DOI: 10.1111/J.1749-6632.2009.05242.X |
0.781 |
|
| 2010 |
Pan D, Yan Q, Chen Y, McDonald JM, Song Y. Abstract 96: Conformational and thermodynamics analyses of the regulation of trifluoperazine on camodulin binding to Fas: Implications for cancer chemotherapy Cancer Research. 70: 96-96. DOI: 10.1158/1538-7445.Am10-96 |
0.42 |
|
| 2010 |
Jing G, Turk AN, Sun Y, Pawar P, Chen Y, McDonald JM. Abstract 126: Gemcitabine enhances therapeutic effect of tamoxifen on cholangiocarcinoma Cancer Research. 70: 126-126. DOI: 10.1158/1538-7445.Am10-126 |
0.757 |
|
| 2009 |
Byon CH, Hardy RW, Ren C, Ponnazhagan S, Welch DR, McDonald JM, Chen Y. Free fatty acids enhance breast cancer cell migration through plasminogen activator inhibitor-1 and SMAD4. Laboratory Investigation; a Journal of Technical Methods and Pathology. 89: 1221-8. PMID 19752858 DOI: 10.1038/Labinvest.2009.97 |
0.759 |
|
| 2009 |
Pawar P, Ma L, Byon CH, Liu H, Ahn EY, Jhala N, Arnoletti JP, McDonald JM, Chen Y. Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 1288-96. PMID 19228732 DOI: 10.1158/1078-0432.Ccr-08-1150 |
0.783 |
|
| 2009 |
Mamaeva OA, Kim J, Feng G, McDonald JM. Calcium/calmodulin-dependent kinase II regulates notch-1 signaling in prostate cancer cells. Journal of Cellular Biochemistry. 106: 25-32. PMID 19021144 DOI: 10.1002/Jcb.21973 |
0.406 |
|
| 2008 |
Suever JD, Chen Y, McDonald JM, Song Y. Conformation and free energy analyses of the complex of calcium-bound calmodulin and the Fas death domain. Biophysical Journal. 95: 5913-21. PMID 18820240 DOI: 10.1529/Biophysj.108.130542 |
0.404 |
|
| 2008 |
Chen Y, Wang X, Di L, Fu G, Chen Y, Bai L, Liu J, Feng X, McDonald JM, Michalek S, He Y, Yu M, Fu YX, Wen R, Wu H, et al. Phospholipase Cgamma2 mediates RANKL-stimulated lymph node organogenesis and osteoclastogenesis. The Journal of Biological Chemistry. 283: 29593-601. PMID 18728019 DOI: 10.1074/Jbc.M802493200 |
0.348 |
|
| 2008 |
Byon CH, Javed A, Dai Q, Kappes JC, Clemens TL, Darley-Usmar VM, McDonald JM, Chen Y. Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. The Journal of Biological Chemistry. 283: 15319-27. PMID 18378684 DOI: 10.1074/Jbc.M800021200 |
0.768 |
|
| 2008 |
Sham SW, McDonald JM, Micoli KJ, Krishna NR. Solution structure of a calmodulin-binding domain in the carboxy-terminal region of HIV type 1 gp160. Aids Research and Human Retroviruses. 24: 607-16. PMID 18370588 DOI: 10.1089/Aid.2007.0202 |
0.76 |
|
| 2008 |
Pawar PS, Micoli KJ, Ding H, Cook WJ, Kappes JC, Chen Y, McDonald JM. Calmodulin binding to cellular FLICE-like inhibitory protein modulates Fas-induced signalling. The Biochemical Journal. 412: 459-68. PMID 18257744 DOI: 10.1042/Bj20071507 |
0.796 |
|
| 2008 |
Chen Y, Pawar P, Pan G, Ma L, Liu H, McDonald JM. Calmodulin binding to the Fas-mediated death-inducing signaling complex in cholangiocarcinoma cells. Journal of Cellular Biochemistry. 103: 788-99. PMID 17654480 DOI: 10.1002/Jcb.21447 |
0.786 |
|
| 2007 |
Yeo H, Beck LH, Thompson SR, Farach-Carson MC, McDonald JM, Clemens TL, Zayzafoon M. Conditional disruption of calcineurin B1 in osteoblasts increases bone formation and reduces bone resorption. The Journal of Biological Chemistry. 282: 35318-27. PMID 17884821 DOI: 10.1074/Jbc.M702435200 |
0.651 |
|
| 2007 |
Pan G, Ahn EY, Chen Y, Feng G, Reddy V, Jhala NC, McDonald JM. Reciprocal co-expression of Fas and Fas ligand in human cholangiocarcinoma. International Journal of Oncology. 31: 843-50. PMID 17786316 DOI: 10.3892/Ijo.31.4.843 |
0.695 |
|
| 2007 |
Saxena R, Pan G, McDonald JM. Osteoblast and osteoclast differentiation in modeled microgravity. Annals of the New York Academy of Sciences. 1116: 494-8. PMID 17656572 DOI: 10.1196/Annals.1402.033 |
0.612 |
|
| 2007 |
Bi LL, Pan G, Atkinson TP, Zheng L, Dale JK, Makris C, Reddy V, McDonald JM, Siegel RM, Puck JM, Lenardo MJ, Straus SE. Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib. Bmc Medical Genetics. 8: 41. PMID 17605793 DOI: 10.1186/1471-2350-8-41 |
0.403 |
|
| 2007 |
Isales CM, McDonald JM. Future developments in therapy. Annals of the New York Academy of Sciences. 1117: 258-63. PMID 17584984 DOI: 10.1196/Annals.1402.000 |
0.319 |
|
| 2007 |
Yeo H, Beck LH, McDonald JM, Zayzafoon M. Cyclosporin A elicits dose-dependent biphasic effects on osteoblast differentiation and bone formation. Bone. 40: 1502-16. PMID 17392048 DOI: 10.1016/J.Bone.2007.02.017 |
0.676 |
|
| 2006 |
Pan G, Kilby M, McDonald JM. Modulation of osteoclastogenesis induced by nucleoside reverse transcriptase inhibitors. Aids Research and Human Retroviruses. 22: 1131-41. PMID 17147500 DOI: 10.1089/Aid.2006.22.1131 |
0.442 |
|
| 2006 |
Chen Y, Xu J, Jhala N, Pawar P, Zhu ZB, Ma L, Byon CH, McDonald JM. Fas-mediated apoptosis in cholangiocarcinoma cells is enhanced by 3,3'-diindolylmethane through inhibition of AKT signaling and FLICE-like inhibitory protein. The American Journal of Pathology. 169: 1833-42. PMID 17071604 DOI: 10.2353/Ajpath.2006.060234 |
0.8 |
|
| 2006 |
Zhu ZB, Chen Y, Makhija SK, Lu B, Wang M, Rivera AA, Yamamoto M, Wang S, Siegal GP, Curiel DT, McDonald JM. Survivin promoter-based conditionally replicative adenoviruses target cholangiocarcinoma. International Journal of Oncology. 29: 1319-29. PMID 17016667 DOI: 10.3892/Ijo.29.5.1319 |
0.327 |
|
| 2006 |
Yeo H, McDonald JM, Zayzafoon M. NFATc1: a novel anabolic therapeutic target for osteoporosis. Annals of the New York Academy of Sciences. 1068: 564-7. PMID 16831953 DOI: 10.1196/Annals.1346.053 |
0.644 |
|
| 2006 |
Pan G, Yang Z, Ballinger SW, McDonald JM. Pathogenesis of osteopenia/osteoporosis induced by highly active anti-retroviral therapy for AIDS. Annals of the New York Academy of Sciences. 1068: 297-308. PMID 16831930 DOI: 10.1196/Annals.1346.057 |
0.31 |
|
| 2006 |
Micoli KJ, Mamaeva O, Piller SC, Barker JL, Pan G, Hunter E, McDonald JM. Point mutations in the C-terminus of HIV-1 gp160 reduce apoptosis and calmodulin binding without affecting viral replication. Virology. 344: 468-79. PMID 16229872 DOI: 10.1016/J.Virol.2005.08.033 |
0.791 |
|
| 2006 |
Seales EC, Micoli KJ, McDonald JM. Calmodulin is a critical regulator of osteoclastic differentiation, function, and survival. Journal of Cellular Biochemistry. 97: 45-55. PMID 16216008 DOI: 10.1002/Jcb.20659 |
0.8 |
|
| 2005 |
Zayzafoon M, Meyers VE, McDonald JM. Microgravity: the immune response and bone. Immunological Reviews. 208: 267-80. PMID 16313354 DOI: 10.1111/J.0105-2896.2005.00330.X |
0.772 |
|
| 2005 |
Meyers VE, Zayzafoon M, Douglas JT, McDonald JM. RhoA and cytoskeletal disruption mediate reduced osteoblastogenesis and enhanced adipogenesis of human mesenchymal stem cells in modeled microgravity. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 20: 1858-66. PMID 16160744 DOI: 10.1359/Jbmr.050611 |
0.78 |
|
| 2005 |
Wu X, Ahn EY, McKenna MA, Yeo H, McDonald JM. Fas binding to calmodulin regulates apoptosis in osteoclasts. The Journal of Biological Chemistry. 280: 29964-70. PMID 15965236 DOI: 10.1074/Jbc.M500710200 |
0.807 |
|
| 2005 |
Zhang L, McKenna MA, Said-Al-Naief N, Wu X, Feng X, McDonald JM. Osteoclastogenesis: the role of calcium and calmodulin. Critical Reviews in Eukaryotic Gene Expression. 15: 1-13. PMID 15831075 DOI: 10.1615/Critreveukaryotgeneexpr.V15.I1.10 |
0.488 |
|
| 2005 |
Jhala NC, Vickers SM, Argani P, McDonald JM. Regulators of apoptosis in cholangiocarcinoma. Archives of Pathology & Laboratory Medicine. 129: 481-6. PMID 15794670 DOI: 10.1043/1543-2165(2005)129<481:Roaic>2.0.Co;2 |
0.333 |
|
| 2005 |
Wu X, Pan G, McKenna MA, Zayzafoon M, Xiong WC, McDonald JM. RANKL regulates Fas expression and Fas-mediated apoptosis in osteoclasts. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 20: 107-16. PMID 15619676 DOI: 10.1359/Jbmr.041022 |
0.588 |
|
| 2005 |
Zayzafoon M, Fulzele K, McDonald JM. Calmodulin and calmodulin-dependent kinase IIalpha regulate osteoblast differentiation by controlling c-fos expression. The Journal of Biological Chemistry. 280: 7049-59. PMID 15590632 DOI: 10.1074/Jbc.M412680200 |
0.385 |
|
| 2004 |
Meyers VE, Zayzafoon M, Gonda SR, Gathings WE, McDonald JM. Modeled microgravity disrupts collagen I/integrin signaling during osteoblastic differentiation of human mesenchymal stem cells. Journal of Cellular Biochemistry. 93: 697-707. PMID 15660414 DOI: 10.1002/jcb.20229 |
0.792 |
|
| 2004 |
Xu D, Shi Z, McDONALD J, Pan G, Cao X, Yu X, Feng X. Development of a chimaeric receptor approach to study signalling by tumour necrosis factor receptor family members Biochemical Journal. 383: 219-225. PMID 15250821 DOI: 10.1042/Bj20040961 |
0.337 |
|
| 2004 |
Pan G, Wu X, McKenna MA, Feng X, Nagy TR, McDonald JM. AZT enhances osteoclastogenesis and bone loss. Aids Research and Human Retroviruses. 20: 608-20. PMID 15242537 DOI: 10.1089/0889222041217482 |
0.539 |
|
| 2004 |
Zayzafoon M, Gathings WE, McDonald JM. Modeled microgravity inhibits osteogenic differentiation of human mesenchymal stem cells and increases adipogenesis. Endocrinology. 145: 2421-32. PMID 14749352 DOI: 10.1210/En.2003-1156 |
0.394 |
|
| 2004 |
Zayzafoon M, Abdulkadir SA, McDonald JM. Notch signaling and ERK activation are important for the osteomimetic properties of prostate cancer bone metastatic cell lines. The Journal of Biological Chemistry. 279: 3662-70. PMID 14602722 DOI: 10.1074/Jbc.M308158200 |
0.39 |
|
| 2004 |
Ahn EY, Lim ST, Cook WJ, McDonald JM. Calmodulin binding to the Fas death domain. Regulation by Fas activation. The Journal of Biological Chemistry. 279: 5661-6. PMID 14594800 DOI: 10.1074/Jbc.M311040200 |
0.698 |
|
| 2003 |
Williams JP, Thames AM, McKenna MA, McDonald JM. Differential effects of calmodulin and protein kinase C antagonists on bone resorption and acid transport activity. Calcified Tissue International. 73: 290-6. PMID 14667143 DOI: 10.1007/S00223-002-0012-2 |
0.376 |
|
| 2003 |
Ahn EY, Pan G, Oh JH, Tytler EM, McDonald JM. The combination of calmodulin antagonists and interferon-gamma induces apoptosis through caspase-dependent and -independent pathways in cholangiocarcinoma cells. The American Journal of Pathology. 163: 2053-63. PMID 14578204 DOI: 10.1016/S0002-9440(10)63563-8 |
0.718 |
|
| 2003 |
Wu X, McKenna MA, Feng X, Nagy TR, McDonald JM. Osteoclast apoptosis: the role of Fas in vivo and in vitro. Endocrinology. 144: 5545-55. PMID 12960091 DOI: 10.1210/En.2003-0296 |
0.582 |
|
| 2003 |
Zhang L, Feng X, McDonald JM. The role of calmodulin in the regulation of osteoclastogenesis. Endocrinology. 144: 4536-43. PMID 12960067 DOI: 10.1210/En.2003-0147 |
0.488 |
|
| 2003 |
Williams JP, McKenna MA, Thames AM, McDonald JM. Effects of cyclosporine on osteoclast activity: inhibition of calcineurin activity with minimal effects on bone resorption and acid transport activity. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 18: 451-7. PMID 12619929 DOI: 10.1359/Jbmr.2003.18.3.451 |
0.362 |
|
| 2003 |
Wang Q, Xie Y, Du QS, Wu XJ, Feng X, Mei L, McDonald JM, Xiong WC. Regulation of the formation of osteoclastic actin rings by proline-rich tyrosine kinase 2 interacting with gelsolin. The Journal of Cell Biology. 160: 565-75. PMID 12578912 DOI: 10.1083/Jcb.200207036 |
0.514 |
|
| 2002 |
Ahn EY, Pan G, Vickers SM, McDonald JM. IFN-gammaupregulates apoptosis-related molecules and enhances Fas-mediated apoptosis in human cholangiocarcinoma. International Journal of Cancer. Journal International Du Cancer. 100: 445-51. PMID 12115528 DOI: 10.1002/Ijc.10516 |
0.699 |
|
| 2002 |
Vickers SM, Jhala NC, Ahn EY, McDonald JM, Pan G, Bland KI. Tamoxifen (TMX)/Fas induced growth inhibition of human cholangiocarcinoma (HCC) by gamma interferon (IFN-gamma). Annals of Surgery. 235: 872-8. PMID 12035045 DOI: 10.1097/00000658-200206000-00016 |
0.669 |
|
| 2001 |
Falany ML, Thames AM, McDonald JM, Blair HC, McKenna MA, Moore RE, Young MK, Williams JP. Osteoclasts secrete the chemotactic cytokine mim-1. Biochemical and Biophysical Research Communications. 281: 180-5. PMID 11178977 DOI: 10.1006/Bbrc.2001.4307 |
0.39 |
|
| 2000 |
Shi XM, Blair HC, Yang X, McDonald JM, Cao X. Tandem repeat of C/EBP binding sites mediates PPARgamma2 gene transcription in glucocorticoid-induced adipocyte differentiation. Journal of Cellular Biochemistry. 76: 518-27. PMID 10649448 DOI: 10.1002/(Sici)1097-4644(20000301)76:3<518::Aid-Jcb18>3.0.Co;2-M |
0.426 |
|
| 2000 |
Micoli KJ, Pan G, Wu Y, Williams JP, Cook WJ, McDonald JM. Requirement of calmodulin binding by HIV-1 gp160 for enhanced FAS-mediated apoptosis. The Journal of Biological Chemistry. 275: 1233-40. PMID 10625668 DOI: 10.1074/Jbc.275.2.1233 |
0.798 |
|
| 2000 |
Pickens A, Pan G, McDonald JM, Vickers SM. Fas expression prevents cholangiocarcinoma tumor growth. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 3: 374-81; discussion 3. PMID 10482689 DOI: 10.1016/S1091-255X(99)80053-5 |
0.402 |
|
| 2000 |
Williams JP, McKenna MA, Thames III AM, McDonald JM. Tamoxifen inhibits phorbol ester stimulated osteoclastic bone resorption: An effect mediated by calmodulin Biochemistry and Cell Biology. 78: 715-723. DOI: 10.1139/O00-084 |
0.404 |
|
| 1999 |
Pan G, Vickers SM, Pickens A, Phillips JO, Ying W, Thompson JA, Siegal GP, McDonald JM. Apoptosis and tumorigenesis in human cholangiocarcinoma cells. Involvement of Fas/APO-1 (CD95) and calmodulin. The American Journal of Pathology. 155: 193-203. PMID 10393851 DOI: 10.1016/S0002-9440(10)65113-9 |
0.452 |
|
| 1998 |
Pan G, Zhou T, Radding W, Saag MS, Mountz JD, McDonald JM. Calmodulin antagonists inhibit apoptosis of CD4+ T-cells from patients with AIDS Immunopharmacology. 40: 91-103. PMID 9826024 DOI: 10.1016/S0162-3109(98)00018-6 |
0.375 |
|
| 1998 |
Pickens A, Pan G, McDonald J, Vickers S. Involvement of fas in tamoxifen-induced apoptosis of cholangiocarcinoma Gastroenterology. 114: A1417. DOI: 10.1016/S0016-5085(98)85762-4 |
0.31 |
|
| 1997 |
Williams JP, McDonald JM, McKenna MA, Jordan SE, Radding W, Blair HC. Differential effects of tamoxifen-like compounds on osteoclastic bone degradation, H(+)-ATPase activity, calmodulin-dependent cyclic nucleotide phosphodiesterase activity, and calmodulin binding. Journal of Cellular Biochemistry. 66: 358-69. PMID 9257192 DOI: 10.1002/(Sici)1097-4644(19970901)66:3<358::Aid-Jcb8>3.0.Co;2-O |
0.375 |
|
| 1997 |
Williams JP, Blair HC, McDonald JM, McKenna MA, Jordan SE, Williford J, Hardy RW. Regulation of osteoclastic bone resorption by glucose. Biochemical and Biophysical Research Communications. 235: 646-51. PMID 9207213 DOI: 10.1006/Bbrc.1997.6795 |
0.304 |
|
| 1997 |
Jo H, Sipos K, Go YM, Law R, Rong J, McDonald JM. Differential effect of shear stress on extracellular signal-regulated kinase and N-terminal Jun kinase in endothelial cells. Gi2- and Gbeta/gamma-dependent signaling pathways. The Journal of Biological Chemistry. 272: 1395-401. PMID 8995450 DOI: 10.1074/Jbc.272.2.1395 |
0.367 |
|
| 1996 |
Radding W, Pan ZQ, Hunter E, Johnston P, Williams JP, McDonald JM. Expression of HIV-1 envelope glycoprotein alters cellular calmodulin. Biochemical and Biophysical Research Communications. 218: 192-7. PMID 8573130 DOI: 10.1006/Bbrc.1996.0034 |
0.312 |
|
| 1995 |
Williams JP, Jo H, Hunnicutt RE, Brautigan DL, McDonald JM. Tyrosine phosphorylation of phosphatase inhibitor 2. Journal of Cellular Biochemistry. 57: 415-22. PMID 7768977 DOI: 10.1002/Jcb.240570307 |
0.333 |
|
| 1994 |
Radding W, Williams JP, Hardy RW, McDonald JM, Whitaker CH, Turbat-Herrera EA, Blair HC. Calmodulin concentrated at the osteoclast ruffled border modulates acid secretion. Journal of Cellular Physiology. 160: 17-28. PMID 8021295 DOI: 10.1002/Jcp.1041600104 |
0.386 |
|
| 1994 |
Williams JP, Jo H, Sacks DB, Crimmins DL, Thoma RS, Hunnicutt RE, Radding W, Sharma RK, McDonald JM. Tyrosine-phosphorylated calmodulin has reduced biological activity. Archives of Biochemistry and Biophysics. 315: 119-26. PMID 7526800 DOI: 10.1006/Abbi.1994.1479 |
0.326 |
|
| 1991 |
Wong ECC, Saffitz JE, McDonald JM. Association of calmodulin with isolated nuclei from rat hepatocytes Biochemical and Biophysical Research Communications. 181: 1548-1556. PMID 1764103 DOI: 10.1016/0006-291X(91)92115-Z |
0.313 |
|
| 1990 |
Davis HW, McDonald JM. Modulation of guanine nucleotide effects on the insulin receptor by MgCl2. Biochemical and Biophysical Research Communications. 171: 53-9. PMID 2118351 DOI: 10.1016/0006-291X(90)91355-V |
0.345 |
|
| 1989 |
Fujita-Yamaguchi Y, Kathuria S, Xu Q, McDonald JM, Nakano H, Kamata T. In vitro tyrosine phosphorylation studies on RAS proteins and calmodulin suggest that polylysine-like basic peptides or domains may be involved in interactions between insulin receptor kinase and its substrate Proceedings of the National Academy of Sciences of the United States of America. 86: 7306-7310. PMID 2552437 DOI: 10.1073/Pnas.86.19.7306 |
0.305 |
|
| 1987 |
Pershadsingh HA, Shade DL, McDonald JM. Stimulation Of Glucose Transport By Insulin, Vanadate, Concanavalin A, Hydrogen Peroxide, And Phorbol Ester Occur By A Calcium-Dependent Mechanism Calcium-Binding Proteins in Health and Disease. 201-203. DOI: 10.1016/B978-0-12-521040-9.50039-5 |
0.3 |
|
| 1982 |
Goewert RR, Landt M, McDonald JM. Calmodulin binding to rat adipocyte plasma membrane: Characterization and photoaffinity cross-linking of calmodulin to binding proteins Biochemistry. 21: 5310-5315. DOI: 10.1021/Bi00264A029 |
0.304 |
|
| Show low-probability matches. |